Fundraising FoxFoley Ventures — Full Portfolio
6 tracked investments · listed companies and verified rows first
Foundersuite offers a software platform for fundraising and investor relations, including an investor database, CRM, warm-intro tools, investor updates, data rooms, and deal documents.
Enterprise SoftwareFintechSaaS
Nathan Beckord(Founder)in
Co-investorsFf Venture CapitalTiger Global Management
Aesthetic-medicine biopharma behind KYBELLA (deoxycholic acid) injection, acquired by Allergan in 2015 for ~$2.1 billion.
Allen Chao(Founder)
Co-investorsAisling CapitalARCH Venture PartnersMESA VERDE VENTURE PARTNERSProspect Venture PartnersSchooner CapitalALTITUDE LIFE SCIENCE VENTURES+2 more
Delafield, US
Kurt Heikkinen(Chief Executive Officer and President)Judy Owen(Director)Jill Larsen(Director)David Matre(Executive Officer)James Pavlik(Director)William Schleicher(Director)
Co-investorsBeringea
Papa is a platform that connects older adults and families with trained companion caregivers for in-home companionship and support services.
ConsumerDigital HealthHealthtechSocialWellness & FitnessMiami, US
Andrew Parker(Founder and CEO)inAlfredo Vaamonde(Co-Founder of Papa; Director)inCharles Hector(Executive Officer)Amit Salam(Senior Technical Recruiter)
BoardByron Ling(Director)inFatima Husain(Director)in
Co-investorsComcast VenturesCanaan PartnersCapital B Private HoldingsFJ LabsInitialized CapitalIntegra Groupe+14 more
Text Blaze is a productivity tool that creates text snippets and templates to reduce repetitive typing across web applications.
Developer ToolsEnterprise SoftwareFuture of WorkSaaSSan Francisco, US
Dan Barak(Founder)inScott Fortmann-Roe(Founder)inGaurang Tandon(Engineer)
Co-investorsFourth RealmY CombinatorBossa InvestGlobal Founders CapitalParadox CapitalSusa Ventures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.